Meeting Schedule 2014

If you wish to provide comments at the November 4, 2014 meeting, registration is required. We request that you limit the time for presenting your comments and limit your presentation to new information, (within the last six months). If you are a manufacturer it is requested you limit you conversation to comparative evidence.

Please include in your email the following: 1. Name of presenter 2.Company/organization affiliation 3.State if the speaker is being compensated in any way for speaking on behalf of the drug, including if the speaker receives compensation as a consultant, is a member of that pharmaceutical company’s speaker’s bureau, or participates in other educational speaking assignments, or receives other funding directly or indirectly through his/her clinic from the pharmaceutical company. Speakers should be prepared to give this information about themselves at the beginning of their public comments.